Primary renal well-differentiated neuroendocrine tumors: report of six cases with an emphasis on the Ki-67 index and mitosis

被引:0
|
作者
Bohyun Kim
Han-Seong Kim
Kyung Chul Moon
机构
[1] Seoul National University College of Medicine,Department of Pathology
[2] Inje University College of Medicine,Department of Pathology
来源
关键词
Renal well-differentiated neuroendocrine tumor; Ki-67; Carcinoid tumor; Mitosis; Grade; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Primary renal well-differentiated neuroendocrine tumour: A case report
    Cardoso, M.
    Pignatelli, A.
    Oliveira, T.
    Ferreira, C.
    VIRCHOWS ARCHIV, 2016, 469 : S337 - S338
  • [22] Predictive value of preoperative MRI features for the Ki-67 index in well-differentiated G1/G2 pancreatic neuroendocrine tumors
    Sun, Haitao
    Zhang, Shilong
    Liu, Kai
    Zhou, Jianjun
    Wang, Xingxing
    Shen, Tingting
    Wang, Xiaolin
    ACTA RADIOLOGICA, 2019, 60 (11) : 1394 - 1404
  • [23] 18F-FDG Uptake in Well-Differentiated Neuroendocrine Tumors Correlates with Both Ki-67 and VHL Pathway Inactivation
    Bucau, Margot
    Laurent-Bellue, Astrid
    Pote, Nicolas
    Hentic, Olivia
    Cros, Jerome
    Mikail, Nidaa
    Rebours, Vinciane
    Ruszniewski, Philippe
    Lebtahi, Rachida
    Couvelard, Anne
    NEUROENDOCRINOLOGY, 2018, 106 (03) : 274 - 282
  • [24] PET+10 Study: Efficacy of Platin/Etoposide Combination in Well-Differentiated Pancreatic Neuroendocrine Tumors with Ki-67 ≥10%
    Roquin, G.
    Baudin, E.
    Lombard-Bohas, C.
    Cadiot, G.
    Dominguez, S.
    Guimbaud, R.
    Niccoli, P.
    Legoux, J. L.
    Rohmer, V
    Ruszniewski, P.
    Caroli-Bosc, F. X.
    Hentic, O.
    NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 269 - 269
  • [25] Kit protein (CD117) and proliferation index (Ki-67) evaluation in well and poorly differentiated neuroendocrine tumors
    Ferrari, Leonardo
    Della Torre, Silvia
    Collini, Paola
    Martinetti, Antonia
    Procopio, Giuseppe
    De Dosso, Sara
    Bajetta, Roberto
    Catena, Laura
    TUMORI JOURNAL, 2006, 92 (06): : 531 - 535
  • [26] Can Ki-67 with 5.5% Be Better in Predicting Prognosis for Well Differentiated Pancreatic Neuroendocrine Tumors?
    Yuan, B.
    Chen, Y. Y.
    Zhang, P.
    Wang, X.
    Tan, H. D.
    Li, Y.
    Qi, Z.
    Luo, J.
    Yang, Z. Y.
    Tan, H. Y.
    NEUROENDOCRINOLOGY, 2020, 110 : 131 - 131
  • [27] Grading of Well-differentiated Pancreatic Neuroendocrine Tumors Is Improved by the Inclusion of Both Ki67 Proliferative Index and Mitotic Rate
    McCall, Chad M.
    Shi, Chanjuan
    Cornish, Toby C.
    Klimstra, David S.
    Tang, Laura H.
    Basturk, Olca
    Mun, Liew Jun
    Ellison, Trevor A.
    Wolfgang, Christopher L.
    Choti, Michael A.
    Schulick, Richard D.
    Edil, Barish H.
    Hruban, Ralph H.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2013, 37 (11) : 1671 - 1677
  • [28] Primary Renal Well-Differentiated Neuroendocrine Tumors: Analyis of Six Cases from a Tertiary Care Center in North India with Review of Literature
    Kumari, Neha
    Verma, Ritu
    Agrawal, Vinita
    Singh, Uday Pratap
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2023, 31 (06) : 982 - 992
  • [29] Primary renal well-differentiated neuroendocrine tumors with lymph node metastasis: A case report and literature review
    Nguyen, Huy-Hoang
    Phan, Hoang-Giang
    Ho, Duc-Thuong
    Le, Van-Hung
    IJU CASE REPORTS, 2025,
  • [30] O6-Methylguanine DNA Methyltransferase (MGMT) Expression and Ki-67 Index Predict Response to Temozolomide in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumors (WDPNET)
    Cros, J.
    Hentic, O.
    Rebours, V
    Zappa, M.
    Maire, F.
    Hammel, P.
    Levy, P.
    Ruszniewski, P.
    Couvelard, A.
    NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 254 - 254